No takes yet. Share an insight, caveat, or question.
Difference-in-differences analysis reveals reduced performance and risk in publicly traded firms, indicating significant economic trade-offs from board quotas.
Yang et al. (2019) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: